Scientech Research’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
Other funds holding CCCC
LCM
Scientech Research's CCCC Position: Q2 2026 in Review
Scientech Research opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 21,260 shares worth $99.3K. The stake represents 0.08% of the portfolio and ranks #178 among its holdings.
148 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.
- Scientech Research held 21,260 shares of C4 Therapeutics worth $99.3K as of Q2 2026.
- C4 Therapeutics was a new Scientech Research position in Q2 2026.
- C4 Therapeutics made up 0.08% of Scientech Research's portfolio in Q2 2026, its #178 holding.
- 148 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.